Abstract:How enhancers regulate their target genes in the context of 3D chromatin organization is extensively studied and models which do not require direct enhancer-promoter contact have recently emerged. Here, we use the activation of estrogen receptor-dependent enhancers in a breast cancer cell line to study enhancer-promoter communication at two loci. This allows high temporal resolution tracking of molecular events from hormone stimulation to efficient gene activation. We examine how both enhancer-promoter spatial proximity assayed by DNA fluorescence in situ hybridization, and contact frequencies resulting from chromatin in situ fragmentation and proximity ligation, change dynamically during enhancer-driven gene activation. These orthogonal methods produce seemingly paradoxical results: upon enhancer activation enhancer-promoter contact frequencies increase while spatial proximity decreases. We explore this apparent discrepancy using different estrogen receptor ligands and transcription inhibitors. Our data demonstrate that enhancer-promoter contact frequencies are transcription independent whereas altered enhancer-promoter proximity depends on transcription. Our results emphasize that the relationship between contact frequencies and physical distance in the nucleus, especially over short genomic distances, is not always a simple one. Investigating the three-dimensional organization of the genome is important for understanding how enhancers regulate their target genes. Commonly, exploring 3D genome organization uses either an imaging-based method—DNA fluorescence in situ hybridization, or molecular chromosome conformation capture methods. Here we use a cell system of nuclear hormone induced enhancer and gene activation to compare what insight into enhancer–gene promoter interaction these methodologies provide. To our surprise, we found that these two methods can produce paradoxical results, with increased enhancer-promoter contact frequencies assayed by chromosome conformation capture occurring in a situation where imaging shows overall decreased enhancer-promoter proximity. We explore what might contribute to these seemingly discrepant data, demonstrating that whereas increased enhancer-promoter contact frequencies require binding of an active transcription factor to the enhancer but are independent of transcription per se, altered enhancer-promoter proximity depends on transcription. Our analyses show the importance of using orthogonal methods to fully explore 3D genome organization.

Estrogen Induces Global Reorganization of Chromatin Structure in Human Breast Cancer Cells

Epigenomics-based Identification of Oestrogen-Regulated Long Noncoding RNAs in ER+ Breast Cancer.

Monkey Multi-Organ Cell Atlas Exposed to Estrogen

Genome-wide Analysis Uncovers High Frequency, Strong Differential Chromosomal Interactions and Their Associated Epigenetic Patterns in E2-mediated Gene Regulation

Estrogen-induced chromatin looping changes identify a subset of functional regulatory elements

Integration of RNA-seq and Ribosome Profiling to Characterize Transcriptional and Translational Estrogen Responses of Genes in Human Breast Cancer

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators

Epigenetic factors that control estrogen receptor alpha (ERα) binding site utilization and specificity in the MCF-7 human breast cancer cell line

Transcription decouples estrogen-dependent changes in enhancer-promoter contact frequencies and spatial proximity

Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation

Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions

Whole-Genome Cartography of Estrogen Receptor Α Binding Sites

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer

Transcriptional Activation Of Nlp By Estrogen-Er Alpha In Breast Cancer

A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer

Abstract IA20: Hormonal action in breast cancer: Common features and unique properties that drive tumor development and outcome

Segregating activities of the estrogen receptor in gene regulation

Mapping of the estrogen receptor: GATA-3 interactome in MCF-7 human mammary carcinoma cells

Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity and tumor-specific looping-mediated biological pathways

Estrogen and DNA damage modulate mRNA levels of genes involved in homologous recombination repair in estrogen-deprived cells

ER is an RNA-binding protein sustaining tumor cell survival and drug resistance